AXSM - Axsome Therapeutics stock rises on upgrade to Overweight at Morgan Stanley
2024-04-29 10:08:15 ET
More on Axsome Therapeutics
- Axsome: Unpacking Auvelity's First-Year Market Dynamics And Economic Challenges
- Axsome Therapeutics, Inc. (AXSM) Q4 2023 Earnings Call Transcript
- Baird starts Axsome at outperform, cites upcoming data
- Axsome Therapeutics Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Axsome Therapeutics